Radium-223

Radium-223

Radiochemicals

Description
Radium-223 dichloride is an alpha particle-emitting radiotherapy drug that mimics calcium and forms complexes with hydroxyapatite at areas of increased bone turnover. The principal use of radium-223, as a radiopharmaceutical to treat metastatic cancers in bone, takes advantage of its chemical similarity to calcium, and the short-range of the alpha radiation it emits.

Status
Inquire

Radionuclidic purity
—

Radiochemical purity
>—%

Chemical formula
—

Concentration
—

Specific activity
—

Half life
11.4 days

Calibration
—

Form
—

Regions
Africa, Asia, Australia, Canada, Europe, Latin America, Middle East, USA